BioCorRx Inc. (BICX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 350K 700K 1.1M Q4 '20: 122.6K Q1 '21: 95.8K Q2 '21: 77.9K Q3 '21: 56.9K Q4 '21: 48.3K Q1 '22: 58.7K Q2 '22: 59K Q3 '22: 144.6K Q4 '22: 213.8K Q1 '23: 233.8K Q2 '23: 237.4K Q3 '23: 153.1K Q4 '23: 89.2K Q1 '24: 52.3K Q2 '24: 36.7K Q3 '24: 26.6K Q4 '24: 7.7K Q1 '25: 138.9K Q2 '25: 313.1K Q3 '25: 948.4K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Gross Profit TTM

0 500K 1M 1.5M Q4 '11: 371.3K Q1 '12: 482.1K Q2 '12: 360.6K Q3 '12: 143.2K Q4 '12: 465.7K Q1 '13: 672.2K Q2 '13: 1M Q3 '13: 1.3M Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13

Operating Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -5.9M Q4 '21: -5.5M Q1 '22: -5.1M Q2 '22: -5.5M Q3 '22: -4.8M Q4 '22: -4.7M Q1 '23: -4.6M Q2 '23: -4.2M Q3 '23: -4.2M Q4 '23: -3.8M Q1 '24: -3.7M Q2 '24: -4.1M Q3 '24: -4.8M Q4 '24: -5.1M Q1 '25: -5.1M Q2 '25: -5.1M Q3 '25: -5.4M Q4 '25: -4.8M Q1 '26: -4.8M Q2 '26: -4.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-6M -4M -2M 0 2M 4M 6M Q3 '21: -4.9M Q4 '21: -5.2M Q1 '22: -4.6M Q2 '22: -4.8M Q3 '22: -4.4M Q4 '22: -4.4M Q1 '23: -4.4M Q2 '23: -4M Q3 '23: -4M Q4 '23: -3.8M Q1 '24: -4M Q2 '24: -4.3M Q3 '24: -4.9M Q4 '24: -5.1M Q1 '25: -4.7M Q2 '25: -4.7M Q3 '25: -5.2M Q4 '25: -4.5M Q1 '26: -4.5M Q2 '26: -4.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 35K 70K 105K Q3 '20: 93.2K Q4 '20: 95.9K Q1 '21: 73.6K Q2 '21: 47.9K Q3 '21: 32.4K Q4 '21: 5.9K Q1 '22: 6.8K Q2 '22: 7.7K Q3 '22: 9K Q4 '22: 15.3K Q1 '23: 22.4K Q2 '23: 30.1K Q3 '23: 31.6K Q4 '23: 36K Q1 '24: 29K Q2 '24: 18.6K Q3 '24: 14.7K Q4 '24: 1.7K Q1 '25: 0 Q2 '25: 0 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25

Operating Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3.2M Q4 '21: -3.5M Q1 '22: -3.5M Q2 '22: -2.5M Q3 '22: -2.2M Q4 '22: -2M Q1 '23: -1.6M Q2 '23: -1.8M Q3 '23: -1.8M Q4 '23: -1.9M Q1 '24: -1.8M Q2 '24: -1.4M Q3 '24: -1.4M Q4 '24: -1.1M Q1 '25: -1.4M Q2 '25: -1.4M Q3 '25: -1.7M Q4 '25: -2.3M Q1 '26: -2M Q2 '26: -2.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '14: 167.2K Q4 '16: -2.3M Q2 '19: -2.1M Q3 '19: -2.6M Q4 '19: -3.1M Q4 '14 Q4 '16 Q2 '19 Q3 '19 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '15: 19.8M Q2 '15: 151.8M Q1 '16: 25.5M Q1 '17: 355.9M Q2 '17: 579.7M Q1 '18: 1.8M Q2 '18: 250.5M Q1 '19: 2.4M Q1 '20: 1.1M Q1 '21: 1.1M Q1 '22: 1.1M Q1 '23: 1.8M Q1 '24: 2.9M Q2 '24: 9.5M Q3 '24: 10.9M Q1 '25: 15.1M Q2 '25: 17M Q3 '25: 18.2M Q1 '26: 25.6M Q2 '26: 29.2M Q2 '15 Q2 '17 Q1 '19 Q1 '22 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '16: -0.03 Q4 '16: -0.03 Q1 '17: -0.22 Q2 '17: -0.19 Q3 '17: -0.17 Q4 '17: -12.82 Q1 '18: -13.04 Q2 '18: -13.06 Q3 '18: -13.81 Q4 '18: -2.10 Q1 '19: -2.36 Q2 '19: -3.03 Q3 '19: -2.61 Q4 '19: -1.72 Q1 '25: -0.41 Q2 '25: -0.35 Q3 '25: -0.32 Q4 '25: -0.19 Q1 '26: -0.16 Q2 '26: -0.12 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.